The revision knee replacement market is likely to rise to USD 1.3 Billion in 2022. The revision knee replacement market is estimated to reach USD 2 Billion with a CAGR of 4.1% by 2032.
Report Attribute | Details |
---|---|
Revision Knee Replacement Market Value (2022) | USD 1.3 Billion |
Revision Knee Replacement Market Anticipated Forecast Value (2032) | USD 2 Billion |
Revision Knee Replacement Market Projected Growth Rate (2022 to 2032) | 4.1% |
Demand for revision knee replacement is likely to rise among elder patients to implant the artificial knee joint or replace it with a new prosthesis. This is likely to grow the revision knee replacement market share. Through these processes, the patient easily and comfortably replaces their damaged knee and is regarded to raise the adoption of revision knee replacement in the coming years.
Rising the adoption of revision knee replacement also includes the use of bone grafts. The bone graft can be an auto-graft that is taken from the site in the patient’s body or an allograft where the bone tissue comes from a donor.
These factors are helping in knee replacement which is anticipated to increase the revised knee replacement market share during the forecast period. There are three major purposes in the revision of knee replacement that is relieving pain in the affected area, restoring mobility, and removing damaged prosthesis.
Total knee replacement surgery is the most successful, but over time if it fails due to various reasons, then revision knee replacement is done. Such advantages lead to an increase in the adoption of revision knee replacement in the health sectors across the countries.
Revision knee replacement also relieves the pain and improves function in different ways as another advantage that would boost the demand for revision knee replacement during the projection period.
Revision knee replacement surgeries are more complex and take longer time, and extensive planning and specialized implants and tools are required to achieve finer results. These surgeries are increasingly getting adopted by the patient to recover from knee replacement more easily and are strengthening the revision knee replacement market share.
There is various type of revision surgery, but in certain cases, only implants are replaced, making it the largest segment and are anticipated to grow the revision knee replacement market size. In other cases, the tibia, femoral and patellar components need to be replaced, and bone around the knee needs to rebuild with the metal piece.
This segment is anticipated to attract some greater revenue for the global revision knee replacement market during the forecast period.
In revision surgery, the old femoral component is removed carefully, and the damaged bone is scraped off. After that, the femur bone is reshaped. If the bone is weak, the cavity inside the femur is filled with bone grafts. This long and safe process is suitable for such patients that have boosted the demand for revision knee replacement across all economies.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The revision of knee replacement market opportunities is expected to grow due to the increasing rate of old age diseases like obesity, arthritis, sports-related injuries, osteoporosis, and diabetes. These opportunities are likely to raise the revised knee replacement market share during the forecast period.
However, existing and upcoming advancements such as minimally invasive surgery and better implant materials are expected to drive the revision knee replacement market demand globally. Increasing investment in the healthcare sector is also expected to supplement the revision knee replacement market size during the forecast period.
Despite the widely used procedures for curing diseases by the revision knee replacement, it is facing challenges, including economic slowdown. This can restrain the revision knee replacement market growth to some degree. High-cost surgery and growing non-surgical treatment methods such as exercise, walking aids, and weight loss may also affect the revision knee replacement market trends.
Also, some patients reconsider elective surgeries during conservative medical treatments such as visco-supplementation to ease the pain. This option has also emerged as another factor that may decline the revision knee replacement market share in the future.
North America dominates the global revision knee replacement market by acquiring 46.4% of the total share in the current year, 2022.
Due to high patient awareness, increasing healthcare expenditure, and advancements in technology, the revision knee replacement market opportunities have increased over these years. As per the revised knee replacement market survey, the market is predicted to strengthen during the forecast period with import restrictions placed by regional countries around the globe.
The net worth of the Europe revision knee replacement market acquired 28.6% of the global share as per the revision knee replacement market report.
The Europe region is estimated to be the second largest revision knee replacement market size after North America. Due to the increasing prevalence and rapid booming in the medical tourism industry are rising the revision knee replacement market growth in the region.
Some of the key players in the Revision Knee Replacement Market are Smith & Nephew Plc, Wright Medical Group, Inc, Zimmer Holdings, Biomet, Inc., Exactech, Stryker Corporation, DePuy Companies, Inc, B. Braun Melsungen AG, DJO Global, Ortho Development, LimaCorporate S.p.a., SURGICAL INTERNATIONAL, and BEZNOSKA among others.
Whereas some regional players also have a significant presence in the revision knee replacement market.
The revision knee replacement start-up companies are using various new innovative equipment for painless surgeries. Day by day their innovation are surging up in the medical field with their fast and secure treatments.
The key playing industries are focusing on their goal of using various appropriate tactics to expand the revision knee replacement market growth. Some of the methods are mergers, acquisitions, product launches, acquisitions, and partnerships among others.
Recent Developments in the Revision Knee Replacement Market are:
One orthopedic start-up company named Monogram is reinventing surgical robots and implants. The company uses its advanced technology by leveraging excellent imaging, machine learning, pre-operative plans, and 3D-printed implants with the help of advanced surgical robots.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
Report Attribute | Details |
---|---|
Growth Rate | CAGR of 4.1% from 2022 to 2032 |
Base Year for Estimation | 2021 |
Historical Data | 2016 to 2021 |
Forecast Period | 2022 to 2032 |
Quantitative Units | Revenue in USD Million and CAGR from 2022 to 2032 |
Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
Segments Covered | Product Type, Fixation Type, End Users, Region |
Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East and Africa |
Key Countries Profiled | United States of America, Canada, Brazil, Argentina, Germany, United Kingdom, France, Spain, Italy, Nordics, BENELUX, Australia & New Zealand, China, India, ASIAN, GCC Countries, South Africa |
Key Companies Profiled | Smith & Nephew Plc; Wright Medical Group, Inc; Zimmer Holdings; Biomet, Inc.; Exactech; Stryker Corporation; DePuy Companies, Inc; B. Braun Melsungen AG; DJO Global; Ortho Development; Limacorporate S.p.a.; SURGIVAL INTERNATIONAL; BEZNOSKA |
Customization | Available Upon Request |
The revised knee replacement market is likely to grow at 4.1% through 2032.
The North American region holds 46.4% of the revision knee replacement market.
The revised knee replacement market worth USD 1.3 Billion in 2022.
The revised knee replacement market is likely to reach USD 2 Billion by 2032.
Estimated Market Size (2024E) | USD 1.4 billion |
---|---|
Projected Market Value (2034F) | USD 2.5 billion |
Value-based CAGR (2024 to 2034) | 5.5% |
Estimated Market Size (2024E) | USD 10,069.3 million |
---|---|
Projected Industry Value (2034F) | USD 13,143.3 million |
Value-based CAGR (2024 to 2034) | 2.70% |
Market Value (2023) | USD 6.4 Billion |
---|---|
Market Value (2033) | USD 25.4 Billion |
CAGR (2023 to 2033) | 14.8% |
Explore Therapeutic Device Insights
View ReportsThank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.